Condition: Overweight and Obese Volunteers · Sponsor: MindRank AI Ltd
To investigate the safety and tolerability after single and multiple ascending doses of MDR-001 Tablets administered orally in healthy participants and obese/ overweight participants.
This description comes directly from the study's public registry record.
Ruowen Guo · +86 0571-85233836 · ruowen.guo@mindrank.cn
Always discuss trial participation with your own doctor first.
| The first hospital of Jilin University | Changchun, Jilin, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06778850